Siga Technologies (SIGA) Non Operating Income (2010 - 2025)
Siga Technologies' (SIGA) quarterly Non Operating Income came in at $1.9 million in Q3 2025, up 40.3% YoY from $1.3 million in Q3 2024, and up 17.23% on a QoQ basis from $1.6 million in Q2 2025.
Siga Technologies (SIGA) Non Operating Income (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Non Operating Income data on file, last reported at $1.9 million in Q3 2025.
- Quarterly Non Operating Income rose 40.3% year-over-year to $1.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $6.7 million (up 14.19% YoY) and the FY2024 annual result came in at $6.1 million, up 45.24% from the prior year.
- Non Operating Income rose to $1.9 million in Q3 2025, from $1.6 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.9 million in Q1 2024 to a low of $23322.0 in Q1 2022.
- A 5-year average of $889464.5 and a median of $1.0 million in 2022 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2021 — Non Operating Income tumbled 93.8% — and 2022, when it jumped 3881.37%.
- Tracing SIGA's Non Operating Income over 5 years: stood at $25117.0 in 2021, then jumped by 3881.37% to $1.0 million in 2022, then gained by 23.55% to $1.2 million in 2023, then increased by 22.14% to $1.5 million in 2024, then climbed by 23.7% to $1.9 million in 2025.
- The last three Non Operating Income figures came in at $1.9 million (Q3 2025), $1.6 million (Q2 2025), and $1.7 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Siga Technologies | 211.95 Mn | 56.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 883,148.00 |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | 890,629.00 |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 258,975.00 |
| Jun 30, 2022 | 72,373.00 |
| Mar 31, 2022 | 23,322.00 |
| Dec 31, 2021 | 25,117.00 |
| Sep 30, 2021 | 26,252.00 |
| Jun 30, 2021 | 24,235.00 |
| Mar 31, 2021 | 25,568.00 |
| Dec 31, 2020 | 62,859.00 |